The global Genetic Toxicology market size is predicted to grow from US$ 241760 million in 2025 to US$ 341250 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.

Genetic toxicology is a branch of toxicology that focuses on the study of the genetic damage or mutations caused by various physical, chemical, and biological agents. These agents, often referred to as genotoxic agents, have the potential to alter the genetic material within cells, including DNA, which can lead to mutations or other genetic changes. Genetic toxicology is an important field for assessing the safety of various substances, including pharmaceuticals, chemicals, environmental pollutants, and radiation.

Increased Regulatory Scrutiny: Regulatory agencies worldwide continue to emphasize the importance of genetic toxicology testing in assessing the safety of pharmaceuticals, chemicals, and various products. The demand for such testing is likely to remain high as regulations evolve.

Advancements in Testing Methods: The field of genetic toxicology has seen advances in testing methods and technologies. This includes the development of more sensitive and specific assays, high-throughput screening, and the use of 3D cell culture models, which enhance the accuracy and efficiency of testing.

Growing Demand for In Vitro Testing: Theres a shift toward in vitro (test tube or cell-based) genetic toxicology testing, which can reduce the need for animal testing and offer faster and more cost-effective results. This is in line with broader trends in reducing animal testing.

Assessment of Genomic Data: With the increasing availability of genomic data, theres a trend toward integrating genomics and bioinformatics into genetic toxicology studies. This allows for a deeper understanding of mechanisms and the identification of genetic biomarkers for toxicity.

LPI (LP Information) newest research report, the ?Genetic Toxicology Industry Forecast? looks at past sales and reviews total world Genetic Toxicology sales in 2024, providing a comprehensive analysis by region and market sector of projected Genetic Toxicology sales for 2025 through 2031. With Genetic Toxicology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Toxicology industry.

This Insight Report provides a comprehensive analysis of the global Genetic Toxicology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Toxicology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetic Toxicology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Toxicology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Toxicology.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Toxicology market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Genotoxicity Screening Assays
    GLP Standard Genotoxicity Assays

Segmentation by Application:

    Mini Ames/Ames
    Gene Mutation
    In Vitro Micronucleus
    Chromosome Aberration
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Frontage Laboratories
    Accelera
    Charles River
    Pharmaron
    Labcorp
    Syngene
    Vivotecnia
    Technics
    Aurigene Pharmaceutical Services
    ERBC Group
    NextGen
    Cardinal Health
    Toxys
    Abbott Toxicology
    Evotec
    EPL